Patient engagement in clinical trials
-
Upload
martin-kelly -
Category
Healthcare
-
view
139 -
download
1
Transcript of Patient engagement in clinical trials
Partnering with Patients for Clinical Trials 2016 A HealthXL Report on improving patient engagment in clinical trials
The Leading Global Platform for Digital Health Collaboration
2
Table of Contents
Editorial
The Challenge
Catalysing the Community: Clinical Advisors
Marketplace Review
Suggested Experiment
Your Personalised View of the Digital Health Market
Appendix 1 - Market Breakout
3
4
5
7
11
12
14
3
Editorial: Patients as Partners in Clinical Trials
Only 2-5% of adult US cancer population is enrolled in Clinical Trials
The pharmaceutical research enterprise is under tremendous pressure to innovate in order
to discover new drugs and commercialize their portfolio more effectively. The average cost
to develop a drug is $2.6 Billion and takes 10 yearsi. This model is unsustainable. To make
matters worse, upon launch, enterprises learn that patients may not value the intervention
as expected.
Traditionally, clinical trials have suffered from a number of challenges including enrolling
patients, identifying trial sites, reducing study drop-off rates, to name a few. 80% of industry
clinical trials do not meet patient recruitment timelines and the current drop-off rate across
all trials is 30%. There is also increasing pressure on clinical trial providers to become
“patient centric”, to leverage technology, and to push the envelope on how health is
measured.
What’s the solution? How does one create a more effective research enterprise? The answer
is more straightforward than we might think – partner with patients. Lets make patients
consider clinical trials a care option.
A number of key trends make this easier. First of all, patients are more self empowered than
ever before and are seeking to get involved. Solutions can further streamline the process by
meeting patients where they are – making the clinical trials easy, convenient, and
accessible . Virtual clinical trials, remote data capture via wearables, and research through
care delivery are just a few things that can delight patients while improving the overall
research process.
For example, in the area of oncology, a number of care solutions aimed at providers capture
tumor type underlying genetics, and treatment effectiveness – which can act as parameters
to assess trial eligibility. Further, a number of patient communities and real-world evidence
solutions enable researchers to access patients and learn about patient’s needs more
directly, and even enable patients to co-design studies.
With all the changes happening within clinical trials, we invite you to read this report that
highlights a number of solutions and approaches to next-generation clinical trials.
4
HealthXL Challenge
Improve patient engagement in clinical trials by creating a landscape in which it is
simple for a patient to find and participate in a clinical trial. Patients consider clinical
trials as a care option and have the power to find out themselves which clinical trial
they are eligible for.
Vision
Taking cancer patients as a model group, the challenge is to meet the planned
enrollment of patients in 90% of trials and to reduce patient ‘drop-off by 20% in trials
via the implementation of digital methods to improve the patient experience in
clinical trials.
Challenge
• Involve the patient at the earliest possible planning stages to ensure the trial
design and protocol will match a patient’s lifestyle and needs.
• Empower the patient to be able to identify the trails that he/she are eligible for
without the need to always go through clinical providers and clinicians.
• Explore other technologies that offer the patients the opportunity to connect and
engage more meaningfully with both clinical trial organisers and other patients.
Defining the challenge
5
Industry Advisors
HealthXL has a large and growing community of advisors made up of clinicians, healthcare industry professionals, venture capitalists, payors, serial entrepreneurs, and innovators.
The top experts in patient engagment in Clinical Trials within the HealthXL community are:
Catalysing the Community
Martin Kohn Chief Medical Scientist
Sentrian
Martin Naley Founder
Cure Forward
Colm Galligan Medical Director
MSD
Dr Galligan has extensive experience in setting up multinational phase 2,3 & 4 clinical trials as well as supporting the development of Investigator Sponsored studies
Dr. Kohn is an alumnus of MIT, Harvard Medical School and NYU and is a fellow of both the American College of Emergency Physicians and the American College of Physician Executives.
Martin is the founder of Cure Forward, who help people get tested, get their data, and then put their data to use to understand their disease and find options for treatment, including clinical trials.
Brendan Buckley Chief Medical Officer
Icon
Jamie Goldfarb Patient Advocate
Cindy Geoghegan Patient Advocate
Brendan has extensive experience in clinical trials and chairs several independent Data and Safety Monitoring Boards for medium to large cardio-metabolic and rare disease clinical studies
Cindy and Jamie are both cancer survivors, Cindy a breast cancer survivor and Jamie melanoma. They both now represent the patient community as advocates, and each participated in clinical trials that led to the treatment of their cancer.
Industry Advisors
Catalysing the Community
6
7
HealthXL reviewed the digital technology marketplace, focusing on companies that could potentially address the Challenge set.
Solutions that addressed the challenge set were found to have one of more of he following capabilities: patient finder for clinical trial (CT) organiser, CT finder for patient, CT finder for physician, virtual clinical trial, tool to personalise clinical trial for patients, education, real world data leverage, electronic informed consent software, ride share company to get patient to CT.
Solutions that put the patient at the centre of the clinical trial were selected as the most effective at engaging patients in clinical trials. HealthXL chose the top 3 capabilities addressing patient engagement in clinical trials. They were 1) CT finder for patient, 2) virtual clinical trial, 3) tool to personalize clinical trial for patient,.
Marketplace Review
CT finder for patient
Virtual clinical trial
Tool to personalize clinical trial for patient
Online database of ongoing clinical trials informing patients what CTs specific to their disease are available.
Clinical trial that is conducted online - from patient enrollment to measuring biometrics, to monitoring progress.
Aids patient in finding clinical trial suited exactly to their disease type and needs.
8
Companies Designing Clinical Trials for Patients
Name
Science 37
Mytrus
ePatient Finder
Patients Like Me
Thread Research
Circulation
VitalTrax
TrialX
Transparency Life Sciences
See Appendix 1 for description of companies listed.
Software to streamline patient recruitment
Database for patients to source clinical trials
Metasite mobile based CT paltform
Remote patient reserch platform
Database for patients to source clinical trials
Leverages real world oncology data to improve CT design
Electronic informed consent software
Ride share to get patient to trial site.
Connects physicians to CTs for their patient
Crowd Sourced Clinical Trials platform
Writes and organise CT info in a easily understandable way
Patients educate each other on CTs available
Strata Oncology
Match late stage cancer patients to clinical trials
Patient Finder for Clinical Trial Organiser
Clinical Trial Finder for patient
Clinical Trial Finder for Physician
Virtual Clinical Trial
Tool to Personalise Clnical Trial for patients
Education Misc.
Flat Iron
Custodix Custodix is the driving force behind real world data collection
Patient Finder for Clinical Trial Organiser
Clinical Trial Finder for patient
Clinical Trial Finder for Physician
Virtual Clinical Trial
Tool to Personalise Clnical Trial for patients
Education Misc.
9
Companies Designing Clinical Trials for Patients See Appendix 1 for description of companies listed.
Crowdsourced database of all clinical trials
Assists in finding personalised CTs for patients via Trial Exchange forum.
Cure Forward
Kayentis
Open Trials
Antidote
FindmeCure
One Voice
Neoclinical
Clinithink
Double Blinded
Trinetix
Molecular Match
Connects patients with clinical trials
Provides genomic sequencing test for patient
Educates patients on the science behind their cancer
Helps patients understand treatments that are available
Patient community for Orphan Disease patients
Database for patients to source clinical trials
Registered nurses help patients to find clinical trials
Provides lists of patients based on trial protocol eligibility
Motivational messages, alerts, reminders, integrated into eCOA solution
Crowd Sourced Clinical Trials platform
Helps cancer patients find CTs
Helps cancer patients find CTs
Name
Through screening and referrals, finds patients for CROs
Researchers can see patients with specific genetic data on Trial Echange Forum.
10
Capability CT finder for patient – informs patient on ongoing CTs
Antidote connects patients with clinical trials by organizing the world’s research information and presenting it to patients.
How do they engage the patient?
Partners
Based
Founded
Science 37 is a mobile based clinical trials company that removes geographical barriers for patients allowing them to bring research into their homes.
Cure Forward provides patients with a genomic sequencing test which they can use to find their best suited clinical trial via clinical trial exchange.
Antidote Match uses NLP and AI to help people find their best clinical trial match. Antidote Connect Network is an online network of health portals, patient organizations and advocacy groups aiming to connect patients to clinical trials.
Mobile app Nora is a technology platform that integrates telemedicine technology into the clinical research process enabling patients to engage in remote clinical trials.
JDRF, Healthline, CentreWatch, GALAXY
Science 37 has 29 partners such as Genentech, Novartis, Naked Biome, Harvard Clinical Medical
Cureforward has 12 partners including Novartis and Quintiles, 3 non-profit organisations such as, Fight Colorectal Cancer and Diagnostic Test Providers such as Cynvenio.
UK and US California Boston
2010 2014 2014
Virtual Clinical Trial Tool to personalize clinical trial for patient
Cure Forward’s process is 3 steps: 1.Patient receives genomic sequencing 2.Patient receives test results 3.Patient can post themselves of clinical trials exchange to find best suited trial.
Company
Deep Dive
11
Suggested Experiment
Using a digital health solution improves patient engagement in clinical trials. Patient
recruitment for clinical trials will increase and patient drop off during clinical trials will
decrease.
Working with a Contract Research Organisation the hypothesis would be tested in a
two-armed randomized control oncology trial. Recruitment of oncology patients will
be conducted.
• Control Group – Cancer patients that are recruited without using a digital
intervention, and are not given a digital intervention during the trial.
• Study Group – Cancer patients that are recruited using a digital intervention and
are given a digital intervention during the trial.
• Study length – 6 months, day 1 is the first day patient recruitment for clinical trial.
Show interest
Interested in this challenge?
Hypothesis
Methods
Primary Endpoints:
Taking cancer as a disease category of interest, HealthXL proposes the following
experiment:
• Number of study group patients vs control group patients that enrolled for clinical trial
• Number of of study group patients vs control group patients that stayed in clinical trial
for study length.
12
Bloomberg meets LinkedIn for digital health
The HealthXL Platform brings together key market stakeholders in digital health, and empowers them to collaborate and learn from each other
• Gain global coverage of market intelligence for innovative high growth companies
• Access shared strategic learnings from market thought leaders
• Close the loop for new collaborative projects, bringing together customers, solutions, funders and precise expertise
HealthXL Members:
Request to join the HealthXL Platform today at manage.healthxl.co
Join today
13
With thanks to our member Icon for proposing this challenge
Authors Ruth Coleman Lead Market Analyst, HealthXL
Julie Carty Head of Member Engagement, HealthXL
References
i. 2016, Tufts Centrer for the Study of Drug Development
ii. Fouad et al., 2013. Enrollemnt of patients with lung and colorectal cancers onto clinical trials. Journal Of Oncology
Michael Garrow Business Analyst, HealthXL
Carlos Rodarte HealthXL Advisor
“ The importance of patient engagement in clinical trials shouldn’t be underestimated. Where patients have been engaged in clinical trial design in particular it has proven to substantially improve patient recruitment, retention and overall compliance rates. Wearables continue to grow in their importance in clinical trials capturing more data more accurately while acting as a real-time source of information to patients”.
Tom O’ Leary, Chief Information Officer at Icon
14
Flat Iron is a cloud based software that support the continuum of cancer care. It organizes the world’s oncology information.
Vitaltrax in a cloud based software solution that gives patients guidance with access to clinical trial information and also has eCOA and EDC features.
Double Blinded is a crowdsourced clinical trials platform. Their primary focus is to provide users with a reliable way to determine the effective ness of a given lifestyle decision.
Transparency life sciences is an online network that aim to design clinical trials via crowdsourcing methods and provide open access to clinical trial data without limitations.
Trinetx is a federated data network that connects clinical researchers in real time to the patient populations they are attempting to study.
Science 37 is a mobile based clinical trials company that allows patients to bring research into their homes.
FindMeCure is the “google for clinical trials” - users can search, weigh, and understand treatments in development
Companies 1/3
Appendix 1
PatientsLikeMe is an online network of over 400,000+ patients who can share their knowledge on treatment options, ongoing research, and support each other.
15
Appendix 1
Molecular match helps cancer patients find all trials available for their specific type of cancer.
Strata oncology's goal is to expand late stage cancer patients access to tumor sequencing and precision medicine trials.
TrialX is building an ecosystem of solutions to build a robust online presence for clinical trials.
ePatientfinder connects physician’s and EHR data to clinical trials
Antidote connects patients with clinical trials by organizing the world’s research information and presenting it to patients.
Thread Research is a Turn Key Remote Patient Research and Care Software that enables remote patient research via Apple Researchkit and Carekit.
Companies 2/3
Neoclinical is a group of registered nurses that match patients with clinical trials.
Kayentis design eCOA solutions that are designed to improve clinical trial compliance with solutions that are intuitive, efficient and user friendly for patients.
16
Appendix 1
Cure Forward provides patients with a genomic sequencing test which they can use to find their best suited clinical trial via clinical trial exchange.
Clinithink is CLiX ENRICH for Clinical trails interrogates rich patient data from within EMRs, PROs and and EDC systems to optimize patient recruitment processes.
Circulation is a non-emergency medical transportation service that through its partnership with Uber can assist in physically getting patients to trial sites.
Companies 3/3
OneVoice is a platform for encouragement, knowledge and collaboration in rare diseases. Their platform rareClnical provides information on ongoing rare disease clinical trials.
Mytrus has developed enroll – a mobile informed consensus and patient enrollment platform for clinical trials.
Custodix is a soltuion that collects and shares privacy senstive data. It is the driving force behind the InSite Platform which aims to accelate clinical research by leveraging Real World Data.